Airain Ltd’s Novartis NVS Stock Holding History

Airain Ltd’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-104,021	Closed	-$6.92M	–	992
2017 Q1	$6.92M	Buy	104,021 +12,698	+14%	+$846K	0.34%	85
2016 Q4	$5.96M	Buy	+91,323	New	+$5.92M	0.48%	51
2016 Q2	–	Sell	-23,549	Closed	-$1.53M	–	823
2016 Q1	$1.53M	Buy	+23,549	New	+$1.6M	0.11%	218
2015 Q4	–	Sell	-2,779	Closed	-$229K	–	984
2015 Q3	$229K	Sell	2,779 -27,191	-91%	-$2.42M	0.01%	666
2015 Q2	$2.64M	Buy	+29,970	New	+$2.75M	0.15%	173

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Airain Ltd's NVS Position: Q2 2017 in Review

Airain Ltd sold out of Novartis (NVS) in Q2 2017, closing a stake of 104,021 shares — an estimated $6.92M sold.

Airain Ltd first reported a position in NVS in Q2 2015 and held it in 5 quarters. The position peaked at $6.92M in Q1 2017. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Airain Ltd reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
Airain Ltd sold 104,021 Novartis shares in Q2 2017, an estimated $6.92M.
Airain Ltd first reported a position in Novartis in Q2 2015 and held it in 5 quarters.
Airain Ltd's Novartis position peaked at $6.92M in Q1 2017.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.